List of news
-
Category: UCLH news
Published on: 02 March 2022
His Royal Highness the Prince of Wales officially opened the University College Hospital Grafton Way Building today.
-
Category: Research news
Published on: 28 February 2022
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Category: UCLH news
Published on: 17 February 2022
Scientists and academics from UCL and UCLH have informed a new set of clinical guidelines to aid better diagnosis and management of endometriosis.
-
Category: UCLH news
Published on: 07 February 2022
The Secretary of State for Health and Social Care Sajid Javid came to University College Hospital Grafton Way Building on Friday 4 February 2022.
-
Category: UCLH news
Published on: 02 February 2022
This Mobile Health Clinic has been extensively refurbished and fitted with a new digital portable x-ray camera and modern technologies to speed patient diagnoses and treatment of infectious diseases that will be powered on green energy.
-
Category: Charity news
Published on: 01 February 2022
See how you could take on a challenge and raise money for a great cause.
-
Category: UCLH news
Published on: 24 January 2022
The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.
-
Category: UCLH news
Published on: 21 January 2022
UCLH has teamed up with Air Ambulance Kent Surrey Sussex (KSS) to create an additional module to its Airway Matters, Massive Open Online Course (MOOC).
-
Category: Research news
Published on: 20 January 2022
A third ‘booster’ dose of COVID-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings from the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre and the Francis Crick Institute.
-
Category: Research news
Published on: 17 January 2022
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
